Minireview: Neuroprotective effects of estrogen - New insights into mechanisms of action

Endocrinology

Volumn 142, Issue 3, 2001, Pages 969-973

  Wise, P M ^a   Dubal, D B ^a   Wilson, M E ^a   Rau, S W ^a   Bottner M ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ALZHEIMER DISEASE; BRAIN INJURY; BRAIN ISCHEMIA; HORMONE ACTION; HUMAN; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0035089767     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.3.8033     Document Type: Short Survey

References (91)

1. Cellular and molecular mechanisms of postmenopausal osteoporosis
2. Changes in cardiovascular risk factors during the peri- and postmenopausal years
3. The epidemiology of estrogen replacement therapy and Alzheimer's disease
4. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
5. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript studies of ERα and ERβ expressed in chinese hamster ovary cells
6. Estrogen and the developing brain
7. Sexual differentiation of the vertebrate brain: Principles and mechanisms
8. Novel mechanisms of estrogen action in the brain: New players in an old story
9. Estrogens: Trophic and protective factors in the adult brain
10. Gender differences in acute CNS trauma and stroke: Neuroprotective effects of estrogen and progesterone
11. Endocrine modulation of the neurotoxicity of gp120: Implications for AIDS-related dementia complex
12. Mechanisms of estrogen protection against HIV proteins, methamphetamme and cocaine neurotoxicity
13. Estrogen for Alzheimer's disease in women: Randomized, double-blind, placebo-controlled trial
14. Estrogen to treat Alzheimer's disease: Too little, too late? So what's a woman to do?
15. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: A controlled study
16. Neuroprotective effects of estrogens: Potential mechanisms of action
17. Estrogen as a neuroprotectant in stroke
18. Cholinergic and anticholinergic drug effects on survival during hypoxia: Significant gender differences
19. CuZn-superoxide dismutase (CuZnSOD) transgenic mice show resistance to the lethal effects of methylenedioxyamphetamine (MDA) and of methylenedioxymethamphetamine (MDMA)
20. Estrogen and coronary heart disease in women
21. An overview of the epidemiology of stroke
22. Sex differences in postischemic neuronal necrosis in gerbils
23. Gender-linked brain Injury in experimental stroke
24. Effects of gender and estradiol treatment on focal brain ischemia
25. Genetic and gender influences on sensitivity to focal cerebral ischemia in the stroke-prone SHR
26. Gender differences in infarct size in mice after permanent focal ischemia and in the protective effects of CuZn superoxide dismutase over expression
27. Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat
28. Estrogen improves biochemical and neurologic outcome following traumatic brain injury in male rats, but not females
29. Estradiol exerts neuroprotective effects when administered after ischemic insult
30. Estradiol protects against ischemic injury
31. Nuclear estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione
32. Estrogen-regulated developmental neuronal apoptosis is determined by estrogen receptor subtype and the fas/fas ligand system
33. Estradiol reduces differential neuronal phenotypes by activating estrogen receptor α or β
34. Recovery recapitulates ontogeny
35. Estrogen receptor α, not β, is a critical link in estradiol-mediated protection against brain injury
36. Estradiol protects against injury-induced cell death in cortical explant cultures: A role for estrogen receptors
37. Estrogen and NGF synergistically protect terminally diffrentiated, ERα-transfected PC12 cells from apoptosis
38. Stable transfection of PC12 cells with estrogen receptor (ERα): Protective effects of estrogen an cell survival after serum deprivation
39. Trophic effects of estradiol on fetal rat hypothalamic neurons
40. Estrogen protects primary cortical neurons from glutamate toxicity
41. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons
42. Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation
43. The female sex hormone oestrogen as a neuroprotectant
44. Estradiol upregulates Bcl-2 expression in adult brain neurons
45. Estrogen induction of cytochrome coxidase subunit III in rat hippocampus
46. Gonadal steroids regulate the expression of glial fibrillary acidic protein in the adult male rat hippocampus
47. Bidirectional transcriptional regulation of glial fibrillarv, acidic protein by estradiol in vivo and in vitro
48. Estrogen modulation of mRNA levels for the two forms of glutamic acid decarboxylase (GAD) in female rat brain
49. The effects of ovariectomy and estrogen replacement on trkA and choline acetytransferase mRNA expression in the basal forebrain on the adult female Sprague-Dawley rat
50. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats
51. Treatment with estrogen and progesterone affects relative levels of brain derived neurotrophic factor mRNA and protein in different regions of the rat brain
52. Gonadal hormone regulation of insulin-like growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adult rats
53. Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats
54. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement
55. Neurotrophin expression modulated by glucocorticoids and oestrogen in immortalized hippocampal neurons
56. Estrogen modulates the growth-associated protein GAP-43 (neuromodulin) mRNA in the rat preoptic area and basal hypothalamus
57. Estrogen-enhanced neurite growth: Evidence for a selective induction of tan and stable microtubules
58. Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats
59. Altered gene expression in cerebral ischemia
60. Expression of interleukin-1β converting enzyme gene family and bcl-2 gene family in the rat brain following permanent occlusion of the middle cerebral artery
61. Apoptosis-suppressor gene bcl-2 expression after traumatic brain injury in rats
62. Up-regulation of the nedd2 gene encoding an ICE/ced-3-like cysteine protease in the gerbil brain after transient global ischemia
63. Gene expression induced by cerebral ischemia: An apoptotic perspective
64. Decreased expression of bcl-2 and bcl-x mRNA coincides with apoptosis following intracerebral administration of 3-nitropropionic acid
65. Regulation of brain derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage
66. Differential regulation of mRNAs for nerve growth factor, brain-derived neurotropic factor and neurotrophin 3 in the adult rat brain following cerebralischemia and hypoglycemic coma
67. Changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/astrocyte cocultures to kainic acid
68. xL expression and β-amyloid-induced apoptosis: Relevance to Alzheimer's disease
69. Modulation of Bcl-2 expression: A potential component of estrogen protection in NT2 neurons
70. Estradiol modulates Bcl-2 in cerebral ischemia: A potential role for estrogen receptors
71. Immediate early gene regulation by estradiol in ischemic injury
72. Induction of galanin gene expression in estradio-mediated neuroprotection against cerebral ischemia
73. Cerebral vasodilating capacity during forebrain ischemia: Effects of chronic estrogen depletion and repletion and the role of neuronal nitric oxide synthetase
74. Postischemic cerebral blood flow recovery in the female: Effect of 17βestradiol
75. Influence of sex hormones on plasma endothelin levels
76. Oestrogen and progesterone inhibit the stimulated production of endotbelin-1
77. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis
78. Nitric oxide and the brain
79. Estrogen neuroprotection and neuronal NO synthetase in rat transient forebrain ishemia
80. Estrogen, nitric oxide, and cerebral blood flow change during transient forebrain ischemia in tee female rat
81. Free radicals in CNS injury
82. Phenolic A ring requirement for the neuroprotective effects of steroids
83. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship
84. Estrogen hormones reduce lipid peroxidahon in cells and tissues of the central nervous system
85. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties
86. +-ATP-ase activity, glucose transport, and glutamate transport induced by amyloid β-peptide and iron
87. Morphological plasticity of dendritic spines in central neuron, is mediated by activation of cAMP response element binding protein
88. Estrogen rapidly induces the phosphorylation of the cAMP response element binding protein in rat brain
89. Rapid membrane effects of steroids in neuroblastoma cells: Effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription
90. ras/MAP kinase pathway activation by estradiol-receptor complex in MCF-7 cells
91. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons